Rare genetic diseases are expected to fuel the growth of the stem cell therapy market. Thousands of people each year suffer from rare disorders such as thalassemia, phenylketonuria, cystic fibrosis, and others. According to the World Health Organization (WHO), chronic diseases cause 41 million mortalities every year, equivalent to 71% of all mortalities globally.